Platinum Investment Management LTD Cytom X Therapeutics, Inc. Transaction History

Platinum Investment Management LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$1.19 - $1.91 $706,558 - $1.13 Million	-593,747 Reduced 48.29%	635,798 $1.02 Million
Q2 2022 Aug 11, 2022	BUY	$1.53 - $2.89 $381,673 - $720,939	249,460 Added 25.45%	1,229,545 $2.25 Million
Q4 2021 Feb 11, 2022	SELL	$3.87 - $7.39 $379,329 - $724,353	-98,018 Reduced 9.09%	980,085 $4.24 Million
Q2 2021 Aug 11, 2021	BUY	$6.33 - $9.91 $1.85 Million - $2.9 Million	292,204 Added 37.18%	1,078,103 $6.82 Million
Q1 2021 May 13, 2021	BUY	$6.6 - $9.0 $3.18 Million - $4.34 Million	482,434 Added 158.98%	785,899 $6.08 Million
Q4 2020 Feb 12, 2021	BUY	$6.47 - $7.9 $667,969 - $815,603	103,241 Added 51.56%	303,465 $1.99 Million
Q3 2020 Nov 13, 2020	BUY	$6.55 - $8.83 $1.31 Million - $1.77 Million	200,224 New	200,224 $1.33 Million

50.4M

112K

8.3K

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $66M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

Get notified when there are updates to the investment portfolio of Platinum Investment Management LTD, based on Form 13F filings with the SEC.

Stay updated on Platinum Investment Management LTD with notifications on news.